doi:10.1016/j.ejogrb.2005.09.007 134 Mallet, P
El programa fase 3 TRIUMPH se encuentra en curso al momento de redaccin, con desenlaces previstos en reduccin ponderal sostenida (TRIUMPH-1, NCT05929066), control glucmico en diabetes (TRIUMPH-2), apnea obstructiva del sueo (TRIUMPH-3) y desenlaces cardiovasculares (TRIUMPH-Outcomes)
While some patients notice early appetite changes during the first weeks, weight-loss results during the first month are often gradual rather than dramatic
Subjects were educated to recognize symptoms of hypoglycemia and were informed about the steps to be followed in case of such events at home
Pharmaceutical companies invest heavily in clinical trials to establish safety, efficacy, and optimal dosage, which is critical for regulatory approval and market success
Delivery on time as expected